Cargando…
β-Lactamase inhibition profile of new amidine-substituted diazabicyclooctanes
The diazabicyclooctane (DBO) scaffold is the backbone of non-β-lactam-based second generation β-lactamase inhibitors. As part of our efforts, we have synthesized a series of DBO derivatives A1–23 containing amidine substituents at the C2 position of the bicyclic ring. These compounds, alone and in c...
Autores principales: | Iqbal, Zafar, Zhai, Lijuan, Gao, Yuanyu, Tang, Dong, Ma, Xueqin, Ji, Jinbo, Sun, Jian, Ji, Jingwen, Liu, Yuanbai, Jiang, Rui, Mu, Yangxiu, He, Lili, Yang, Haikang, Yang, Zhixiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Beilstein-Institut
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961884/ https://www.ncbi.nlm.nih.gov/pubmed/33777246 http://dx.doi.org/10.3762/bjoc.17.60 |
Ejemplares similares
-
Recent Developments to Cope the Antibacterial Resistance via β-Lactamase Inhibition
por: Iqbal, Zafar, et al.
Publicado: (2022) -
Structural Investigations of the Inhibition of Escherichia coli AmpC β-Lactamase by Diazabicyclooctanes
por: Lang, Pauline A., et al.
Publicado: (2021) -
Interactions of the Diazabicyclooctane Serine β-Lactamase
Inhibitor ETX1317 with Target Enzymes
por: Shapiro, Adam B., et al.
Publicado: (2020) -
Durlobactam, a New Diazabicyclooctane β-Lactamase Inhibitor for the Treatment of Acinetobacter Infections in Combination With Sulbactam
por: Shapiro, Adam B., et al.
Publicado: (2021) -
Discovery of an
Orally Available Diazabicyclooctane
Inhibitor (ETX0282) of Class A, C, and D Serine β-Lactamases
por: Durand-Réville, Thomas F., et al.
Publicado: (2020)